Glomeria Therapeutics
Develops and commercialises medical devices to treat nephropathy.
Launch date
Employees
Market cap
-
Enterprise valuation
€4—6m (Dealroom.co estimates Sep 2015.)
Company register number MI2525082
Chieti Abruzzo (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 |
---|---|---|---|
Revenues | <1m | <1m | <1m |
% growth | - | 3031 % | 71 % |
EBITDA | (<1m) | (1.3m) | <1m |
% EBITDA margin | (170959 %) | (10016 %) | 335 % |
Profit | (<1m) | (5.3m) | (<1m) |
% profit margin | (193934 %) | (40242 %) | (387 %) |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
€1.0m | Early VC | ||
€2.8m | Grant | ||
€2.8m | Grant | ||
Total Funding | €6.6m |